StockData
NervGen Pharma Corp. logo

NervGen Pharma Corp. (NGEN) income statement

NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.90−0.06 (-3.06%)

Close on Nov 18, 2026Market cap $151.33MP/E –Yield –

NervGen Pharma Corp. income statement

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
–

Financial strength

Current ratio
1.32
Debt to equity
–
Debt to assets
–
Cash to current liabilities
127.5%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

See a number that looks wrong?